Department of Ophthalmology Grand Rounds

When:
November 21, 2024 @ 8:30 am – 10:00 am
2024-11-21T08:30:00-08:00
2024-11-21T10:00:00-08:00
Where:
HYBRID - VCV013E - William and Ruth Hoffman Auditorium, 1st Floor
490 Illinois Street
San Francisco
CA 94143
Contact:
Meelan Bravo

8:30-9:15am–Case Presentations: Cornea (Dr. Neel Pasricha)

9:15-10:00am–Grand Rounds: “Corneal Innovation Lab: From Bench to Bedside”, Alfonso L. Sabater, MD, PhD

  1. Explore Current Advances in Corneal Regeneration.
  2. Evaluate the Clinical Applications and Future Directions of Corneal Gene Therapy.
  3. Evaluate the Impact of Innovative Devices on Corneal Graft Viability.

Disclosures:  Presenter Dr. Alfonso L. Sabater, MD, PhD has the following financial relationships to disclose: Brill Pharma and GSK – Consultant, Ocubio and Tissuecor – Owner, holder of IP and Laboratorios Sophia – Speaker.
Planner Yvonne Ou, MD, has received research funding from Astellas Institute for Regenerative Medicine and advises for Oculinea and Janssen.

Target Audience: Physicians and Advanced Practice Providers.

Accreditation: In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation: UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This presentation receives support from UCSF’s (non-commercial) Samuel J. Kimura Fund, Transamerica Lecture Fund and Proctor Lecture Fund.